Driving ESG excellence in the pharmaceutical sector through an analytical approach: a roadmap for score improvement
Environmental Science: Advances · 2026 · 5 (1) · 221-238
DOI: 10.1039/d5va00286a ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Science: Advances, 2026. Verfasst von Gursharan Singh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Integrated ESG frameworks strengthens resilience, accountability, and investor trust in India's pharmaceutical manufacturing sector. The study provides a five-step roadmap for improving ESG scores.
Zitieren
APA
Singh, G., & Kumar, A. (2026). Driving ESG excellence in the pharmaceutical sector through an analytical approach: a roadmap for score improvement. Environmental Science: Advances, 5(1), 221-238. https://doi.org/10.1039/d5va00286a
Vancouver
Singh G, Kumar A. Driving ESG excellence in the pharmaceutical sector through an analytical approach: a roadmap for score improvement. Environmental Science: Advances. 2026;5(1):221-238. doi:10.1039/d5va00286a
BibTeX
@article{Singh2026,
author = {Singh, Gursharan and Kumar, Ashutosh},
title = {Driving ESG excellence in the pharmaceutical sector through an analytical approach: a roadmap for score improvement},
journal = {Environmental Science: Advances},
year = {2026},
volume = {5},
number = {1},
pages = {221--238},
doi = {10.1039/d5va00286a}
}
EUVIMED